Drugs Health Medical Pharma

Researchers unveil new magnet-controlled ingestible video capsules for endoscopy

HQ Team June 2, 2023: In a first, researchers at George Washington University have used an external magnet to remotely control ingestible video.

Read More
Drugs Health Medical Pharma

Global risk of cholera continues to be ‘very high’: WHO

HQ Team June 2, 2023: Shortage of oral vaccines and overstretched public health and medical professionals are contributing to the spread of cholera,.

Read More
Drugs Health Medical Pharma

Pfizer: ’Positive results’ emerge out of multi-drug-resistant trials

HQ Team June 1, 2023: Pfizer’s last-stage experimental trials for treating multi-drug-resistant bacteria have yielded positive results, the US-based company announced. The Phase.

Read More
Drugs Health Medical Pharma

WHO unveils online repository of 450 psychoactive drugs

HQ Team June 1, 2023: The World Health Organization has posted a repository of more than 450 psychoactive drugs listing their abuses, harms,.

Read More
Drugs Health Medical Pharma

France reports a rapid rise in severe neonatal sepsis since July 2022

HQ Team June 1, 2023: Seven newborns have died in France due to severe neonatal sepsis associated with enterovirus during the more than.

Read More
Climate Health Medical Pharma

Situation in Europe’s largest nuclear plant remains ‘dangerous’: IAEA 

Europe’s largest nuclear plant, the Zaporizhzhya Nuclear Power Plant, in Ukraine, remains “extremely fragile and dangerous” because the war with Russia may escalate,.

Read More
Drugs Health Medical Pharma

Pfizer’s hemophilia trial cure shows 92% cut in bleeds

Pfizer’s hemophilia trial cure shows a 92% cut in bleeds HQ Team May 30, 2023: Pfizer Inc.’s phase III experimental therapy for treating.

Read More
Climate Health Pharma

18 global hotspots set to face severe hunger, UN agencies warn

HQ Team May 30, 2023: Hunger is set to increase in severity and magnitude in 18 global hotspots out of 22 designated nations,.

Read More
Drugs Health Pharma

FDA approves Lexicon’s oral drug for heart failure, type 2 diabetes patients

INPEFA is an inhibitor of both sodium-glucose co-transporter type 2 (SGLT2) and type 1 (SGLT1). This class of SGLT inhibitors was recommended as.

Read More
Drugs Health Medical Pharma

Adult people of color in US at 59% more risk of premature death, researchers say

HQ Team May 27, 2023: Adult people of colour in the US have 59% higher risk of premature deaths than their white counterparts,.

Read More
X